छोड़कर सामग्री पर जाएँ

Alembic Pharma rebounds, up 4% on USFDA nod to Fluorouracil injection

Shares of Alembic Pharma traded higher on Monday after the company received final approval from USFDA for its Fluorouracil Injection 2.5 g/50 mL (50 mg/mL) Pharmacy Bulk Vial.

Read More

​ Shares of Alembic Pharma traded higher on Monday after the company received final approval from USFDA for its Fluorouracil Injection 2.5 g/50 mL (50 mg/mL) Pharmacy Bulk Vial. Shares of Alembic Pharma traded higher on Monday after the company received final approval from USFDA for its Fluorouracil Injection 2.5 g/50 mL (50 mg/mL) Pharmacy Bulk Vial.  Moneycontrol Latest News Read More  

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी